Authors: Chadwick, R ten Have, H Hoedemaekers, R Husted, J Levitt, M McGleenan, T Shickle, D Wiesing, T

Citation: R. Chadwick et al., Euroscreen 2: Towards community policy on insurance, commercialization andpublic awareness, J MED PHIL, 26(3), 2001, pp. 263-272

Authors: Hoedemaekers, R

Citation: R. Hoedemaekers, Commercialization, patents and moral assessment of biotechnology products, J MED PHIL, 26(3), 2001, pp. 273-284

Authors: Hoedemaekers, R

Citation: R. Hoedemaekers, Commercial predictive testing: the desirability of one overseeing body, J MED ETHIC, 26(4), 2000, pp. 282-286

Authors: Hoedemaekers, R ten Have, H

Citation: R. Hoedemaekers et H. Ten Have, The concept of abnormality in medical genetics, THEOR MED B, 20(6), 1999, pp. 537-561

Authors: Hoedemaekers, R

Citation: R. Hoedemaekers, Genetic screening in the Netherlands - The state of the debate, ETHICS OF GENETIC SCREENING, 1999, pp. 105-118

Authors: Hoedemaekers, R

Citation: R. Hoedemaekers, Genetic screening and testing - A moral map, ETHICS OF GENETIC SCREENING, 1999, pp. 207-230